Select a metric from the list below to chart it
Metric | Dec '20 | Dec '21 | Dec '22 | LTM |
---|---|---|---|---|
Total Revenues | 1,535.4 | 4,851.8 | 7,267.4 | 7,895.3 |
Total Revenues % Chg. | — | 216.0% | 49.8% | 414.2% |
Cost of Goods Sold, Total | 1,796.9 | 5,396.5 | 7,537.7 | 7,906.0 |
Gross Profit | -261.5 | -544.7 | -270.2 | -10.6 |
Selling General & Admin Expenses, Total | 365.9 | 1,129.0 | 1,095.5 | 2,337.1 |
Provision for Bad Debts | 3.7 | 39.0 | 35.0 | 14.7 |
R&D Expenses | 14.1 | 41.0 | 44.5 | 42.4 |
Other Operating Expenses | -9.6 | -79.3 | -85.3 | -37.1 |
Other Operating Expenses, Total | 374.1 | 1,129.7 | 1,089.7 | 2,357.1 |
Operating Income | -635.6 | -1,674.5 | -1,359.9 | -2,367.8 |
Interest Expense, Total | -13.8 | -99.1 | -99.5 | -110.9 |
Interest And Investment Income | 7.6 | 20.6 | 33.1 | 32.3 |
Net Interest Expenses | -6.3 | -78.5 | -66.4 | -78.5 |
Income (Loss) On Equity Invest. | -0.3 | 1.2 | -0.3 | -0.2 |
Currency Exchange Gains (Loss) | 29.4 | 19.9 | -17.3 | -5.0 |
Other Non Operating Income (Expenses) | -5.8 | -2.3 | -2.2 | -9.3 |
EBT, Excl. Unusual Items | -618.6 | -1,734.2 | -1,446.2 | -2,460.7 |
Gain (Loss) On Sale Of Investments | — | -4,383.5 | 3,050.7 | 2,043.3 |
Gain (Loss) On Sale Of Assets | -0.0 | -1.4 | -1.9 | -26.6 |
Legal Settlements | — | — | -19.3 | -2.2 |
EBT, Incl. Unusual Items | -618.6 | -6,119.1 | 1,583.3 | -446.3 |
Income Tax Expense | 45.5 | 73.1 | 10.8 | 20.2 |
Earnings From Continuing Operations | -664.2 | -6,192.3 | 1,572.6 | -466.5 |
Minority Interest | 99.3 | 145.3 | 83.6 | 68.2 |
Net Income | -564.8 | -6,047.0 | 1,656.2 | -398.3 |
Net Income to Common Incl Extra Items | -564.8 | -6,047.0 | 1,656.2 | -398.3 |
Net Income to Common Excl. Extra Items | -564.8 | -6,047.0 | 1,656.2 | -398.3 |
Total Shares Outstanding | 595.8 | 514.4 | 4,037.8 | 3,915.2 |
Weighted Avg. Shares Outstanding | 595.8 | 514.4 | 604.5 | 611.9 |
Weighted Avg. Shares Outstanding Dil | 595.8 | 514.4 | 1,444.8 | 611.9 |
EPS | -0.9 | -11.8 | 2.7 | -0.7 |
EPS Diluted | -0.9 | -11.8 | -1.2 | -4.4 |
EBITDA | -594.7 | -1,568.7 | -1,114.0 | -2,127.4 |